Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
EBIT Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -44.9292.58-57.38-14.14442.89

What is the latest EBIT Growth ratio of NGL FINECHEM ?

The latest EBIT Growth ratio of NGL FINECHEM is -44.92 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-44.92
Mar202492.58
Mar2023-57.38
Mar2022-14.14
Mar2021442.89

How is EBIT Growth of NGL FINECHEM Trending?

Years EBIT Growth % Change
Mar2025 -44.92
Negative
Mar2024 92.58
Positive
Mar2023 -57.38
Negative
Mar2022 -14.14
Negative
Mar2021 442.89 -

Other Financial Ratios of NGL FINECHEM


Compare EBIT Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹787.6 Cr -0.2% 10.5% -54.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,273.0 Cr 2.5% 4.1% -0.8% Stock Analytics
DIVIS LABORATORIES ₹176,604.0 Cr 0.5% -2.9% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,316.0 Cr 6.2% 9.3% 17.9% Stock Analytics
CIPLA ₹125,993.0 Cr 4.9% 2.9% 1.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,795.0 Cr 2.1% 1.2% -5% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-0.2%

10.5%

-54.9%

SENSEX

-1.5%

-2.5%

0.2%


You may also like the below Video Courses